Real World Evidence (RWE) Solutions Industry Trends

1
Real World Evidence Solutions Market Trend
Report and Industry Analysis on Real World
Evidence Solutions Market
2
Business Strategies and Consultant
3
Table Of Contents
Business Introduction
Report Segmentation
Market Introduction
Research Methodology
Primary Respondent
Our Services
Continent Breakdown
Contact Us
4
Our Company
Delvens is a market research and consulting
company headquartered in Delhi, India. The
company holds expertise in providing syndicated
research reports, customized research reports,
and consulting services. Delvens qualitative and
quantitative data is highly utilized by each
level from niche markets to major markets,
serving more than 800 prominent companies by
assuring to provide the information on country,
regional, and global business environment. We
have a database for more than 45 industries in
more than 50 major countries globally.
5
Real World Evidence Solutions Market
An Introduction to the Real World Evidence
Solutions
6
Introduction

• Real-world data (RWD) are routinely obtained data
  pertaining to patients' health condition and/or
  the delivery of health care from a range of
  sources. Real-world evidence (RWE) is clinical
  evidence obtained by RWD analysis on the use and
  possible benefits or dangers of a medical
  product. RWE may give information on a variety of
  topics, such as illness natural history and
  progression, efficacy studies, outcome research,
  and safety surveillance. However, the utility of
  RWE is hampered by information variety, vast data
  sets of dubious quality, and methodological
  rigor.
• RCTs are intended to offer strong evidence of a
  premarket review of an experimental product's
  effectiveness and safety. Internal validity is
  prioritized in RCT design, which can occasionally
  compromise generalizability. RWE studies, on the
  other hand, are intended to offer data that is
  relevant to clinical practice.

7

• Today's healthcare sector is more specialized,
  competitive, and cost-conscious than ever before.
  To illustrate the benefit of goods and explain
  complicated healthcare choices, teams across the
  lifecycle require the proper evidence.
  Regulators, payers, prescribers, and patients are
  increasingly accepting of RWE usage, opening up a
  new world of possibilities.
• There are several types and sources of RWD. Let's
  take a deeper look at each category, its origin,
  and its applications.
• Clinical information derived from electronic
  health records (EHRs) and case report forms
  (eCRFs). This data contains information on the
  patient's demographics, family history,
  comorbidities, procedure and treatment history,
  and results.
• Patient-generated information derived from
  patient-reported outcome (PRO) questionnaires.
  These data give direct patient perspectives and
  aid researchers in understanding what happens
  outside of clinic visits, treatments, and
  hospital stays.

8

• Cost and usage information derived from claims
  and public databases. They give data on the use
  of healthcare services, population coverage, and
  prescribing patterns.
• Data on public health from various government
  sources. These provide crucial information to
  stakeholders, allowing them to better address the
  needs of the communities they serve.

9
Cost and usage information derived from claims
and public databases. They give data on the use
of healthcare services, population coverage, and
prescribing patterns. Data on public health from
various government sources. These provide crucial
information to stakeholders, allowing them to
better address the needs of the communities they
serve.
Market Prospect
The global Real-World Evidence (RWE) Solutions
market size is forecasted to reach a CAGR of
14.6 from 2021 to 2028. North America is the
most rapidly growing market and offers a huge
opportunity for the industry, whose growth is
driven by the increased RD in the sector and the
favourable governmental policies. Asia Pacific
was the fastest growing regional market for real
world evidence solutions market in 2020. The
Oncology segment accounted for the largest market
share in 2020.
10
Market Drivers
According to real world evidence solutions market
study analysis, a growing elderly population and
the recent transition from volume- to value-based
care are two reasons that have fueled long-term
growth for the Real World Evidence (RWE)
Solutions Market. Other key factors fueling this
industry's growth are the shift from volume- to
value-based care and drug development delays (and
the associated increase in development costs).
Market growth is predicted to be driven by
regulatory support for the use of real-world
evidence (RWE) solutions, as well as an increase
in RD spending. However, the market's expansion
is being hampered by an inability to rely on
real-world research and the absence of
universally recognized scientific standards for
data collection. COVID-19 had a good market
impact since it became the most widely utilized
and important technology to cope with the
pandemic because it gives a better alternative
and knowledge of the epidemic. The emergence of
this pandemic has put pharma-biopharma firms in a
variety of countries under significant financial
strain. RWE technologies have
11
proven to be quite valuable in this field,
allowing industrial and academic researchers to
monitor patients via digitally linked platforms
while also aiding in the organization and
assessment of clinical data for regulatory
filings.
Conclusions
Clinical registries, which include patient,
product, and claims registries, are not just a
great source of RWD. They are also important
instruments for producing RWE and utilizing RWE
to assist post-market surveillance and research.
It has a great opportunity in market growth.
12
Designation Breakdown
Breakdown of our data collection from People of
different Designation
13
Product Manager
Primary Respondent
CEO
They are the major contributor with 35
30 of our primary respondents
Sales Manager
Distributors
Their contribution is about 25
10 of our data come from them
14
Continent Breakdown

• Breakdown of our data collection from different
  continents

15
(No Transcript)
16
Report Segmentation
Therapeutic Area
Region
End-User
Component
17

• On the basis of Component
• Services
• Data Sets
• Clinical setting data
• Claims data
• Pharmacy data
• Patient powered data
• On the basis of Therapeutic Area
• Oncology
• Cardiovascular
• Neurology
• Immunology
• Others

18

• On the basis of End-User
• Pharmaceutical and Medical Devices Companies
• Healthcare Providers
• Healthcare Payers
• Other End Users
• On the basis of Region
• North America
• South America
• Asia Pacific
• Europe
• Middle East Africa

19
How to Purchase the Report

• Delvens offers many customisation to cater your
  need. Our popular customisation is that our
  report is segmented as per user where you got
  option to choose from
• Single User
• Multiple User
• Corporate User
• If you want report for Globally, Regional or
  Country specific, then voila, we also provide an
  easy step to choose from continent-wise as well
  as country-wise report. If you have any special
  requirement or you want more customization, you
  can contact our customer representative who are
  24X7 available for you.
• You can talk to our representative by clicking

Contact Us
20
No. Of Pages 349
Report Global
Report Regional
Report Country Specific
User Single
User Multi
User Corporate
Get latest and trending updates throughout the
year on the reports you buy.
21
Research Methodology
Market Integration
Data Extraction
Data Analysis
Data Validation
22
Data Extraction The stage involves the
procurement of market data or related information
via different sources methodologies. Data
Analysis This step involves the analysis
mapping of all the information procured from the
previous step. It also encompasses the analysis
of data discrepancies observed across various
data sources. Market Integration The final step
entails the placement of data points at
appropriate market spaces in an attempt to deduce
viable conclusions. Analyst perspective subject
matter expert based heuristic form of market
sizing also plays an integral role in this
step. Data Validation Validation is the most
important step in the process. Validation
re-validation via an intricately designed process
helps us finalize data-points to be used for
final calculations.
23
Our Services
2
Best Practice Guide
1
Syndicated Research
4
Consulting Services
3
Custom Research Services
6
Audio-Video Infographic Workshop
3
5
Implementation Support
3
8
Bundle Reports Model
1
7
Subscription Model
1
24
Thank You